Roundup trial: Bayer’s glyphosate-cancer legal losses signal public’s flagging trust in regulators

large

Jurors have sided with plaintiffs in all three cases over Bayer AG’s herbicide Roundup to go to trial so far, finding that glyphosate causes cancer and awarding a total of more than $2.2 billion in damages.

Those results underscore a growing skepticism of juries to trust the science conducted by regulators, which, if it continues, could have profound impacts on the ability of companies to defend themselves in product liability cases ….

“Over the past 10 years, jurors have become increasingly skeptical of government regulators ….” said Allan Kanner, a plaintiffs’ attorney with Kanner & Whiteley LLC who handles toxic tort cases.

Monsanto, which was acquired by Bayer AG last year and which makes Roundup, has been accused of covering up the chemical’s health risks.

ADVERTISEMENT

Related article:  Video: In search of the mystery glyphosate pathogen with Kevin Folta

Despite losing at trial in each of the three cases to go before a jury, the company remains confident that appellate judges will be more willing to side with the company’s toxicology evidence, which includes findings by both federal and international regulators.

But Kanner said that strategy is based on a premise that regulatory experts still hold a deciding influence over jurors. “That model …. is based on a world view among jurors that no longer exists, or is rapidly eroding,” he said.

Read full, original article: Bayer Jury Awards on Roundup Underscore Legal Rift Over Science

ADVERTISEMENT
ADVERTISEMENT
Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend